<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">107136</article-id>
<article-id pub-id-type="doi">10.7554/eLife.107136</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.107136.2</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.3</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Epidemiology and Global Health</subject>
</subj-group>
</article-categories><title-group>
<article-title>Estimating probabilities of malaria importation in southern Mozambique through <italic>P. falciparum</italic> genomics and mobility patterns</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7288-6435</contrib-id>
<name>
<surname>Pujol</surname>
<given-names>Arnau</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
    <xref ref-type="author-notes" rid="n1">*</xref>
<email>arnau.pujol@isglobal.org</email>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Chidimatembue</surname>
<given-names>Arlindo</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
    <xref ref-type="author-notes" rid="n1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>da Silva</surname>
<given-names>Clemente</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boene</surname>
<given-names>Simone</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mbeve</surname>
<given-names>Henriques</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cisteró</surname>
<given-names>Pau</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>García-Fernández</surname>
<given-names>Carla</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vañó-Boira</surname>
<given-names>Arnau</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tembisse</surname>
<given-names>Dário</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Inácio</surname>
<given-names>José</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matambisso</surname>
<given-names>Glória</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luis</surname>
<given-names>Fabião</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ndimande</surname>
<given-names>Nelo</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Munguambe</surname>
<given-names>Humberto</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nhamussua</surname>
<given-names>Lidia</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Simone</surname>
<given-names>Wilson</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0566-4901</contrib-id>
<name>
<surname>Aranda-Díaz</surname>
<given-names>Andrés</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>García-Ulloa</surname>
<given-names>Manuel</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Canana</surname>
<given-names>Neide</given-names>
</name>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tusell</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Montaña</surname>
<given-names>Júlia</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fuente-Soro</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bapu</surname>
<given-names>Khalid Ussene</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0332-4388</contrib-id>
<name>
<surname>Murphy</surname>
<given-names>Maxwell</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rafael</surname>
<given-names>Bernardete</given-names>
</name>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rovira-Vallbona</surname>
<given-names>Eduard</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guinovart</surname>
<given-names>Caterina</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0287-9111</contrib-id>
<name>
<surname>Greenhouse</surname>
<given-names>Bryan</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Enosse</surname>
<given-names>Sonia Maria</given-names>
</name>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saúte</surname>
<given-names>Francisco</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aide</surname>
<given-names>Pedro</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Candrinho</surname>
<given-names>Baltazar</given-names>
</name>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3890-2897</contrib-id>
<name>
<surname>Mayor</surname>
<given-names>Alfredo</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a8">8</xref>
<xref ref-type="aff" rid="a9">9</xref>
</contrib>
<aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03hjgt059</institution-id><institution>ISGlobal</institution></institution-wrap>, <city>Barcelona</city>, <country country="ES">Spain</country></aff>
<aff id="a2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0287jnj14</institution-id><institution>Centro de Investigação em Saúde de Manhiça</institution></institution-wrap>, <city>Maputo</city>, <country country="MZ">Mozambique</country></aff>
<aff id="a3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/021018s57</institution-id><institution>Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB)</institution></institution-wrap>, <city>Barcelona</city>, <country country="ES">Spain</country></aff>
    <aff id="a4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>EPPIcenter Research Program, Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco</institution></institution-wrap>, <city>San Francisco</city>, <country country="US">United States</country></aff>
<aff id="a5"><label>5</label><institution>Malaria Consortium</institution>, <city>Maputo</city>, <country country="MZ">Mozambique</country></aff>
<aff id="a6"><label>6</label><institution>National Malaria Control Program</institution>, <city>Maputo</city>, <country country="MZ">Mozambique</country></aff>
 <aff id="a7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03hq46410</institution-id><institution>Instituto Nacional de Saúde (INS)</institution></institution-wrap>, <city>Maputo</city>, <country country="MZ">Mozambique</country></aff>
<aff id="a8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05n8n9378</institution-id><institution>Faculty of Medicine, Universidade Eduardo Mondlane</institution></institution-wrap>, <city>Maputo</city>, <country country="MZ">Mozambique</country></aff>
<aff id="a9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/050q0kv47</institution-id><institution>Spanish Consortium for Research in Epidemiology and Public Health (CIBERESP)</institution></institution-wrap>, <city>Madrid</city>, <country country="ES">Spain</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Ferreira</surname>
<given-names>Marcelo U</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of São Paulo</institution>
</institution-wrap>
<city>São Paulo</city>
<country country="BR">Brazil</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Soldati-Favre</surname>
<given-names>Dominique</given-names>
</name>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4156-2109</contrib-id><role>Senior Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/01swzsf04</institution-id><institution>University of Geneva</institution>
</institution-wrap>
<city>Geneva</city>
<country country="CH">Switzerland</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn id="n1" fn-type="equal"><label>*</label><p>These authors contributed equally</p></fn>
<fn fn-type="coi-statement"><p>Competing interests: No competing interests declared</p></fn>
<fn fn-type="supported-by"><p>Funding Statement: This work was supported financially by the Bill and Melinda Gates Foundation (INV-019032, A.M. and INV-067310, A.M.), the Government of Catalonia and co-financed by the European Social Fund of the EU (AGAUR grant 2022 FI_B 00148, S.B. and SGR 01517 to A.M.), the European Union's Horizon 2020 research and innovation programme (Marie Skłodowska-Curie grant 890477, A.P.). The project that gave rise to these results received the support of a fellowship from the &quot;laCaixa&quot; Foundation (ID 100010434). The fellowship code is LCF/BQ/PR24/12050009 (A.P.). The Centro de Investigação em Saúde de Manhiça (CISM) is supported by the Government of Mozambique and the Spanish Agency for International Development Cooperation (AECID). This research is part of ISGlobal's Program on the Molecular Mechanisms of Malaria which is partially supported by the Fundación Ramón Areces. We acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/10.13039/501100011033, and from the Generalitat de Catalunya through the CERCA Program. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2025-07-30">
<day>30</day>
<month>07</month>
<year>2025</year>
</pub-date>
<pub-date date-type="update" iso-8601-date="2025-12-11">
<day>11</day>
<month>12</month>
<year>2025</year>
</pub-date>
<volume>14</volume>
<elocation-id>RP107136</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2025-05-01">
<day>01</day>
<month>05</month>
<year>2025</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2025-05-29">
<day>29</day>
<month>05</month>
<year>2025</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2025.05.01.25326793"/>
</event>
<event>
<event-desc>Reviewed preprint v1</event-desc>
<date date-type="reviewed-preprint" iso-8601-date="2025-07-30">
<day>30</day>
<month>07</month>
<year>2025</year>
</date>
<self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.107136.1"/>
<self-uri content-type="editor-report" xlink:href="https://doi.org/10.7554/eLife.107136.1.sa4">eLife Assessment</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.107136.1.sa3">Reviewer #1 (Public review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.107136.1.sa2">Reviewer #2 (Public review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.107136.1.sa1">Reviewer #3 (Public review):</self-uri>
<self-uri content-type="author-comment" xlink:href="https://doi.org/10.7554/eLife.107136.1.sa0">Author response:</self-uri>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2025, Pujol et al</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Pujol et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-107136-v2.pdf"/>
<abstract><p>Imported malaria is a critical obstacle to achieving elimination in low transmission settings. Characterising malaria importation and transmission sources using human mobility and parasite genomics has the potential to inform elimination strategies, but tools combining both types of data are lacking. We developed a novel Bayesian approach that provides individual importation probabilities and geographic origin of <italic>P. falciparum</italic> cases by combining epidemiological, human mobility and parasite genetic data. Spatial genetic structure and connectivity were assessed using microhaplotype-based genetic relatedness (identity-by-descent) from 1605 <italic>P. falciparum</italic> samples collected from 9 provinces in Mozambique during 2022, including two very-low transmission elimination-targeted districts (Magude and Matutuine) in the south. Travel reports were combined with genetic relatedness metrics to classify clinical cases as local or imported. Genetic relatedness between parasites from southern and northern/central Mozambique was lower (0.021) than average (0.034, p&lt;0.001). 42% (88/207) of infections in elimination-targeted districts were classified as imported, had a higher genetic complexity (OR=1.3) and originated mainly from Inhambane (63% [55/88]). Significant differences in importation rates were found between the two studied districts (OR=6.6), with Magude district (10.71%, 3/28) showing lower importation rates than Matutuine (48.60%, 87/179) district. Differences in importation rates observed between both elimination districts suggest the need for fine-scale analysis to tailor cost-effective elimination strategies. Importation is playing a crucial role in sustaining transmission in Matutuine district, and increasing efforts to reduce malaria burden in their sources of transmission (especially in Inhambane province), as well as targeting travelers to central and northern Mozambique, could significantly contribute to malaria elimination in the south.</p>
</abstract>
<funding-group>
<award-group id="par-1">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000865</institution-id>
<institution>Bill and Melinda Gates Foundation (GF)</institution>
</institution-wrap>
</funding-source>
<award-id>INV-019032</award-id>
<principal-award-recipient>
<name>
<surname>Mayor</surname>
<given-names>Alfredo</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="par-2">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000865</institution-id>
<institution>Bill and Melinda Gates Foundation (GF)</institution>
</institution-wrap>
</funding-source>
<award-id>INV-067310</award-id>
<principal-award-recipient>
<name>
<surname>Mayor</surname>
<given-names>Alfredo</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="par-3">
<funding-source>
<institution-wrap>
<institution>la Caixa Foundation</institution>
</institution-wrap>
</funding-source>
<award-id>100010434</award-id>
<principal-award-recipient>
<name>
<surname>Pujol</surname>
<given-names>Arnau</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="par-4">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000780</institution-id>
<institution>European Commission (EC)</institution>
</institution-wrap>
</funding-source>
<award-id>890477</award-id>
<principal-award-recipient>
<name>
<surname>Pujol</surname>
<given-names>Arnau</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<notes notes-type="disclosures">
<title>Author Declarations</title><p>I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.</p><p>Yes</p><p>The details of the IRB/oversight body that provided approval or exemption for the research described are given below:</p><p>This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. Ethical approval was obtained from the Comite Nacional de Bioetica para Saude (CNBS) Mozambique, affiliated with the Ministerio de Saude (approval number 604/CNBS/21; 1st November 2023). The CNBS can be contacted at: Ministerio de Saude - 2 andar dto, Av. Eduardo Mondlane / Salvador Allende, PC 264, Maputo, Mozambique.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.</p><p>I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.</p><p>Yes</p><p>I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).</p><p>Yes</p><p>I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.</p><p>Yes</p></notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>The manuscript has been revised to address the comments from the eLife reviewers and editors, including a fix in the formula to define the probabilities of being imported given a sample genome.</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Despite the efforts during the last decades, malaria elimination remains challenging, especially in Sub-Saharan Africa<sup><xref ref-type="bibr" rid="c1">1</xref>–<xref ref-type="bibr" rid="c6">6</xref></sup>. Detection, characterisation and monitoring of malaria infections are key to control and elimination<sup><xref ref-type="bibr" rid="c7">7</xref></sup>. However, decisions become more complex in low transmission areas given the heterogeneity in transmission patterns, requiring better tools to identify the key sources of transmission<sup><xref ref-type="bibr" rid="c8">8</xref></sup>.</p>
<p>One of the key challenges for malaria elimination in very-low transmission settings is parasite importation, which can sustain transmission during “last mile” efforts<sup><xref ref-type="bibr" rid="c9">9</xref>–<xref ref-type="bibr" rid="c14">14</xref></sup>. Identifying imported cases and their transmission sources, together with associated risk factors, is key to improving targeted efforts for malaria elimination in very-low transmission areas. Previous studies that aimed to classify reported cases as local or imported used epidemiological data based on travel reports (assuming or modelling that the infections occurred during the trip)<sup><xref ref-type="bibr" rid="c15">15</xref>–<xref ref-type="bibr" rid="c18">18</xref></sup>, or mobile phone data and geospatial modelling to characterise population mobility and infer the potential impact of importation<sup><xref ref-type="bibr" rid="c19">19</xref>–<xref ref-type="bibr" rid="c22">22</xref></sup>. Other studies used parasite genomics to assess the spatial connectivity of genetic populations to infer transmission flow, migration patterns or infection origin<sup><xref ref-type="bibr" rid="c23">23</xref>–<xref ref-type="bibr" rid="c37">37</xref></sup>. However, a study comparing mobility, phone and parasite genetic data brought distinct conclusions on the spatial connectivities due to intrinsic biases of the different data sources<sup><xref ref-type="bibr" rid="c30">30</xref></sup>. Two studies which combined mobility (travel reports and mobile phone data) with genetic data found a positive association between mobility and parasite genetic relatedness, providing evidence of importation<sup><xref ref-type="bibr" rid="c21">21</xref>,<xref ref-type="bibr" rid="c30">30</xref></sup>. However, none of these studies combined mobility and genetic data simultaneously to provide importation rates in the populations or for individual case classification.</p>
<p>We present a new method to provide case classification as individual importation probabilities by combining travel, epidemiological, and <italic>P. falciparum</italic> genetic data. We apply this method in the context of Mozambique, a country with medium-high malaria transmission in central and northern Mozambique and low transmission levels in the south. In particular, we study the role of importation in two southern districts from Maputo province, Magude and Matutuine. Magude is a mainly rural interior district, bordering the National Kruger Park (South Africa), while Matutuine is a district close to Maputo city, with better connection and communication infrastructures and bordering South Africa from the south. The study uses data from children (a common sentinel group for symptomatic cases and surveillance) from 9 (out of 11) provinces of Mozambique to assess the spatial structure (dependence on pairwise geographical distance) and differentiation (across areas) of <italic>P. falciparum</italic> genetic populations in the country, quantify the levels of importation in the very low transmission districts of Magude and Matutuine in southern Mozambique, and identify sources of transmission and risk factors associated with human mobility and malaria importation.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Participant recruitment, sample and data collection</title>
<p>The study was conducted during 2022 in 7 health facilities (HF) of Magude and 13 HF of Matutuine districts, both in Maputo province. All the individuals attending the HF with signs and symptoms of malaria and a positive malaria rapid diagnostic test were included in the study if residing in the study area (Suppl. Fig. 1). These are very-low transmission areas (with less than 52 yearly cases per 1,000 people in all HFs) with the highest rainfall between January and May. A total of 809 <italic>P. falciparum</italic> positive clinical cases were reported, from which 609 (75.3%, 609/809) rapid diagnostic tests (RDTs) were available for parasite sequencing and 540 (66.7%, 540/809) were sequenced successfully (with allele calls passing both negative controls and allele frequency filters, see Methods). Demographic data and travel reports were available for 232 (28.7%, 232/809) of the samples, and 207 (25.6%, 207/809) resided in the area and passed sequencing coverage and depth requirements (at least 50 loci with &gt;100 reads, see Methods section for more details)<sup><xref ref-type="bibr" rid="c38">38</xref>,<xref ref-type="bibr" rid="c39">39</xref></sup> (<xref rid="tbl1" ref-type="table">Table 1</xref>, <xref rid="fig1" ref-type="fig">Fig. 1</xref>). From these 207, 51.7% (107/207) reported a trip during the last 28 days, with 55.1% (59/107) of those having travelled to Inhambane province, the main travel destination (<xref rid="fig2" ref-type="fig">Fig. 2A</xref>, Suppl. Table 1). Travels were represented geographically in <xref rid="fig2" ref-type="fig">Fig. 2B</xref>. The other principal destinations were Zambézia (14.0%, 15/107), Gaza (12.1%, 13/107) and Maputo provinces (9.3%, 10/107). Significant differences were found between clinical cases from Magude and Matutuine districts on travelling rates (p&lt;0.001), with those from Matutuine showing higher travel rates (10.7% [3/28] in Magude versus 58.1% [104/179] in Matutuine, p&lt;0.001), and occupation (p=0.001), but not on season (p=0.060), age (p=0.599), sex (p=0.272), pregnancy (p=1.000) or travel destination (p=0.357) (<xref rid="tbl1" ref-type="table">Table 1</xref>).</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Fig. 1:</label>
<caption><title>Flowchart of the P. falciparum samples and data from Magude and Matutuine districts collected in 2022.</title></caption>
<graphic xlink:href="25326793v3_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Fig. 2:</label>
<caption><title>Statistics of travel reports.</title>
<p><bold>A)</bold> Pie chart showing the distributions of the travel destination provinces in sampled individuals from Maputo province (Magude and Matutuine). Colours show the provinces from blue (south) to red (north). <bold>B)</bold> Spatial connectivity based on travel history. Line widths are proportional to the number of travels reported from Maputo province to their destination province, with the same colors as in A. Maps used OpenStreetMap data, available under the Open Database License.</p></caption>
<graphic xlink:href="25326793v3_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1:</label>
<caption><title>Sample size and characteristics of the P<italic>. falciparum</italic> clinical cases in Magude and Matutuine with travel history data.</title></caption>
<graphic xlink:href="25326793v3_tbl1.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
<p>Additionally, 1,065 dried blood spot samples from <italic>P. falciparum</italic> uncomplicated clinical malaria cases were collected in 9 provinces during the 2022 rainy season, in the context of annual health facility surveys (HFS) or clinical trials<sup><xref ref-type="bibr" rid="c40">40</xref></sup> (Suppl. Figure 1, Suppl. Table 2). The number of samples sequenced per province ranged between 78 and 100, with the exception of Inhambane province which included 364 samples for a deeper spatial analysis in this province (Suppl. Table 2). No significant differences between provinces were found in terms of age (p=0.551) or gender (p=0.575). Analysis were conducted both at province and regional level , where provinces were classified as follows: south (Maputo, Inhambane), centre (Sofala, Manica, Tete, Zambézia) and north (Nampula, Niassa, Cabo Delgado).</p>
</sec>
<sec id="s2b">
<title>Country-wide spatial trends of <italic>P. falciparum</italic> genetic relatedness</title>
<p>DNA extracted from DBS or RDTs was sequenced using the MAD<sup>4</sup>HatTeR targeted amplicon sequencing panel and 165 microhaplotype loci were used to calculate diversity metrics<sup><xref ref-type="bibr" rid="c41">41</xref></sup>. A significant spatial pattern of genetic relatedness (<italic>R</italic>, defined as the fraction of related (identity-by-descent, IBD) pairs (IBD&gt;0.1 and p&lt;0.05), see Methods) in <italic>P. falciparum</italic> populations within and across provinces was found (<xref rid="fig3" ref-type="fig">Fig. 3A</xref>, with a geographical representation of the results in <xref rid="fig3" ref-type="fig">Fig. 3B</xref>) with a strong south-centre/north differentiation (<xref rid="fig3" ref-type="fig">Fig. 3C,D</xref>). Sample pairs within centre/north Mozambique presented a higher <italic>R</italic> (0.06, 10238/181503 pairs) than the average (0.03, 41413/1287210 pairs; p&lt;0.001). However, <italic>R</italic> between south and centre/north sample pairs was lower than average (0.02, 12462/604206 pairs, p&lt;0.001) (Suppl. Fig. 2). The highest <italic>R</italic> was found within Nampula (<italic>R</italic>=0.12 [475/4005 pairs]), and the highest <italic>R</italic> from Maputo province was with Inhambane (<italic>R</italic>=0.04 [8855/231410 pairs]). When stratifying Maputo and Inhambane provinces by district (samples from these provinces were collected in two districts), <italic>R</italic> was higher for sample pairs between Matutuine and Inhambane (<italic>R</italic>&gt;0.04 regardless of the district from Inhambane) than for sample pairs within Matutuine (0.03, 508/15400 pairs) (Suppl. Fig. 3A)(p&lt;0.001, Suppl. Fig. 3B) . Samples from Magude showed lower R than the average when compared with samples from Inhambane (0.03, 77/2816 pairs)(p=0.007), but no significant differences were found when compared to the rest of the districts.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Fig. 3:</label>
<caption><title>Genetic relatedness (identity-by-descent, IBD) of <italic>P. falciparum</italic> infections between provinces and regions in Mozambique.</title>
<p>A) Fraction (<italic>R</italic>) of IBD-related sample pairs (IBD&gt;0.1 with p&lt;0.05) within and between different provinces, represented in colours. B) Spatial genetic connectivity between provinces. Line widths and point sizes are proportional to <italic>R</italic>, and colours show the ranking in <italic>R</italic> values (from blue to red, using turbo colormap). C) <italic>R</italic> between and within different regions (south, centre and north), and combining samples from centre and north (D). N=1605. Maps used OpenStreetMap data, available under the Open Database License.</p></caption>
<graphic xlink:href="25326793v3_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>A strong spatial correlation of <italic>R</italic> at the inter-province scale was found (Suppl. Fig. 4A), with <italic>R</italic> significantly decreasing with the pairwise geographical distance for distances larger than 100 km (p&lt;0.001). However, no significant correlation was found for distances between 10 km and 100 km (p=0.547, p=0.628 and p=0.794 when using IBD thresholds of 0.1, 0.15 and 0.2 respectively, showing that trends do not depend on the threshold used) (Suppl. Fig. 4B). In the shortest distances between zero (the same household) and 10 km, the decrease of <italic>R</italic> with distance became significant again (p&lt;0.001) (Suppl. Fig. 4C).</p>
</sec>
<sec id="s2c">
<title><italic>P. falciparum</italic> importation rates</title>
<p>A new Bayesian approach was used to classify clinical cases as imported and local. The method calculates an individual probability of being imported by combining epidemiological data (household-based mRDT positivity rates in children under 5 years per province from the demographic health survey 2022-2023<sup><xref ref-type="bibr" rid="c42">42</xref></sup>), travel reports (date, duration and destination, interpreting infections as local if no travels were reported) and genetic IBD relatedness (<italic>R’</italic> between the sample and the parasite population in Maputo province, or the travel destination, see Methods) (<xref rid="fig4" ref-type="fig">Fig. 4</xref>). The importation probabilities obtained were in general close to 0 or 1, with only 1.9% (4/207) of them being between 0.25 and 0.75. Cases were classified as imported if their importation probability was higher than 50%. The fraction of imported cases within those who reported travel was 82.2% (88/107), corresponding to an importation rate of 42.5% (88/207) with respect to all cases. Among clinical cases from Magude and Matutuine with travel records, almost half (51.4%; 55/107) reported a trip to Inhambane province, representing 26.6% (55/207) of all studied cases from Magude and Matutuine (<xref rid="tbl2" ref-type="table">Table 2</xref>). Similar results were found when travel duration (or <italic>R’</italic>) were not included in the estimation, being mRDT positivity rates the main driver of importation probabilities (Suppl. Importation analysis, Suppl. Fig. 5, Suppl. Table 3).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Fig. 4:</label>
<caption><title>Distribution of importation probabilities by district.</title>
<p>Distribution of the individual probabilities of being imported for the studied clinical cases from Magude (orange) and Matutuine (blue) districts.</p></caption>
<graphic xlink:href="25326793v3_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2:</label>
<caption><title>Fraction of imported cases per province.</title><p><italic>Weighted number of cases</italic>: the total number of cases (weighted by their probability) imported from each province (n=207). <italic>Imported cases</italic>: the total number of cases classified as imported if P(imported)&gt;50% (n=207). <italic>% cases with travel reports</italic>: The fraction of imported cases from each province with respect to the total of cases reporting travels (n=107). <italic>% all reported</italic>: the total contribution of imported cases from each province with respect to all reported cases in the Maputo province (n=207). <italic>Imported to Magude</italic>: total of imported cases residing in Magude (n=28). <italic>Imported to Matutuine</italic>: total of imported cases residing in Matutuine (n=179).</p></caption>
<graphic xlink:href="25326793v3_tbl2.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
<p>A statistically significant correlation was found between genetic relatedness and travel destinations. Cases reporting travel to Inhambane province presented a higher <italic>R’</italic> with the population from that province than cases reporting travels to other provinces or no travels at all (p&lt;0.001) (Suppl. Table 4). This correlation was not statistically significant for other travel destinations, possibly due to the lower sample sizes of travellers (n&lt;=15).</p>
</sec>
<sec id="s2d">
<title>Risk factor analysis of <italic>P. falciparum</italic> importation</title>
<p>Odds ratios (OR) were calculated using univariate and multivariate Firth’s logistic regressions<sup><xref ref-type="bibr" rid="c43">43</xref></sup> to assess the risk factors associated with malaria importation (n=207; Suppl. Table 5, <xref rid="fig5" ref-type="fig">Fig. 5</xref>). Pregnancy was excluded in the multivariate analysis due to the low number of pregnant women (n=2). The residence district was strongly associated with importation rates in both univariate (p&lt;0.001) and multivariate (p=0.004) analysis, with Magude district presenting a lower rate of importation (10.7%, 3/28) than Matutuine (47.5%, 85/179; OR=6.6, 95%CI (2.3, 25.2), p=0.004). Given that 96.6% (85/88) of the imported cases were from Matutuine district and only 3 were from Magude (<xref rid="tbl2" ref-type="table">Table 2</xref>), the statistics on imported cases, such as importation origin, mainly refer to Matutuine district.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Fig. 5:</label>
<caption><title>Odds ratio statistics of factors associated with importation and travel.</title>
<p>Odds ratio of importation (A-B), reporting travel (C-D) and importation for cases with travel reports (E-F) for different factors in univariate (A, C and E) and multivariate (B, D and F) models, for all <italic>P. falciparum</italic> clinical cases recruited in Magude and Matutuine (n=207 for A-D, n=107 for E and F).</p></caption>
<graphic xlink:href="25326793v3_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>In the univariate analysis, season, occupation and travel destination obtained statistically significant associations, with higher levels of importation in the dry season (OR=2.0, 95%CI (1.1, 3.5), p=0.027), lower importation rates for students (OR=0.3, 95%CI (0.1, 0.8), p=0.013), farmers (OR=0.3, 95%CI (0.1, 0.8), p=0.019) and other occupations (OR=0.4, 95%CI (0.2, 0.8), p=0.009) with respect to unemployed (or minors), and high importation rates (&gt;80%, p&lt;0.001) for cases travelling to Gaza, Inhambane, Zambézia and Nampula (Suppl. Table 5, <xref rid="fig5" ref-type="fig">Fig. 5A</xref>) with respect to Maputo province. No associations were found for sex (p=0.075), pregnancy (p=0.263) or age (p=773). In the multivariate analysis, only the residential district remained a significant factor (p=0.004). No association was found between the rate of importation and parasite density (p=0.691) or any estimation of polyclonality (p&gt;0.052 for any estimate). However, imported cases had a higher COI mean (2.82, 95%CI [1.0,7.7]) and eCOI (1.77, 95%CI [1.0,3.9]) than local cases (2.18, 95%CI (1.0,5.1), p=0.005 and 1.48, 95%CI (1.0,3.3), p=0.008, respectively) (Suppl. Table 5, <xref rid="fig5" ref-type="fig">Fig. 5A</xref>). Similar results were found when assessing association between these estimates and travel reporting (Suppl. Table 6, <xref rid="fig5" ref-type="fig">Fig. 5C,D</xref>).</p>
<p>When restricting the analysis to cases reporting travel (n=107), the only factor that remained informative of importation was the province destination of the travel (p&lt;0.001 for the province destinations of Gaza, Inhambane, Zambézia and Nampula), from both univariate and multivariate analysis (Suppl. Table 7, <xref rid="fig5" ref-type="fig">Fig. 5E,F</xref>). The probability of being imported was above 80% for all travels reported outside Maputo province and Maputo city, where the importation probability was below 10%. Neither parasitemia, COI nor polyclonality were found to be informative of importation.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>Knowledge of the sources of transmission, including imported cases, can inform the tailoring of effective targeted approaches for elimination<sup><xref ref-type="bibr" rid="c40">40</xref>,<xref ref-type="bibr" rid="c44">44</xref></sup>. Here we have developed a novel Bayesian approach that allows the integration of genetic, travel history and epidemiological data to estimate probabilities of malaria importation. This new approach combines pairwise IBD estimates with travel reports to obtain a case-by-case probability of being imported. We found different importation rates between Magude (10.71%, 3/28) and Matutuine districts (47.5%, 85/179; OR=6.6, 95%CI (2.3, 25.2), p=0.004), in Maputo province, identifying Inhambane province as the main transmission source in Matutuine. COI and eCOI, which are within-host markers potentially informative of malaria burden in the population<sup><xref ref-type="bibr" rid="c45">45</xref></sup>, were higher for imported cases, confirming our importation estimates from areas of higher malaria burden.</p>
<p>Our results show we can use parasite genomics to assess genetic population structure at the national level and at very-small scales (at the household level), but not at district level. We observed a high genetic relatedness between <italic>P. falciparum</italic> sample pairs within the centre-north of the country and a lower relatedness between south and centre-north. Pairwise genetic IBD-relatedness significantly decreased with the distance at large geographical scales, suggesting a strong isolation-by-distance at the country level, probably due to different parasite populations having different allele frequencies. No spatial correlation was found between samples at distances between 10 and 100 km, representing intra-province distances, indicating that <italic>P. falciparum</italic> genomics is heterogeneous at the provincial level. However, the spatial correlation was significant again at the smallest scales, including the distance of zero (the same household). This indicates that genetic IBD-relatedness is significantly higher for intra-household pairs, quickly decreasing to show no spatial pattern at small distances. The high relatedness of household members highlights the potential of genomics for very fine-scale transmission modelling approaches, such as transmission network modelling<sup><xref ref-type="bibr" rid="c46">46</xref></sup>. The large-scale genetic structure suggests that <italic>P. falciparum</italic> genomics can be used to assess malaria importation across provinces, but the lack of structure at distances of 10-100 km, maybe due to high mobility in short distances, might challenge the studies on importation within the province (across districts).</p>
<p>Cases notified during the dry season reported more travels (63.1%) and showed higher importation rates (53.8%) than those from the rainy season (46.5% and 37.2% respectively). However, there was no significant association with importation when conditioned to travel, implying that that importation and travel are highly correlated. This indicates that importation is higher precisely when transmission is lower. No association with importation was found for occupation, sex, age or pregnancy, suggesting that targeting specific subpopulations for malaria prevention or control might not be strategic.</p>
<p>A high fraction (51.7%) of <italic>P. falciparum</italic> clinical cases in Magude and Matutuine districts reported a travel in the last 28 days. Among them, a total of 82.2% of these cases were estimated as imported, representing 42.5% of all reported cases studied. Remarkable differences in importation rates were found between Magude (10.7%) and Matutuine (47.5%) districts, as well as in travel rates (10.7% in Magude and 58.1% in Inhambane). Inhambane was found to be the main source of importation in Matutuine, accounting for 63.5% (54/85) of all the imported cases from Matutuine. Genetic relatedness confirmed these mobility patterns, with Matutuine showing higher genetic relatedness with Inhambane than Magude. Several factors can contribute to these different importation patterns. Matutuine district is close to Maputo City (a city with high mobility and importation levels), has better communication infrastructures and has some touristic places (e.g. Ponta do Ouro) of potential importation risk. In contrast, Magude district is an interior rural area, more isolated from big communication hubs, with less mobility due to work and with the National Kruger Park (South Africa) limiting movement in a significant fraction of its border. Further social studies would be required to identify those factors that increase the importation risk in southern Mozambique.</p>
<p>The results of this study have several practical implications for malaria elimination. First, improving the case classification through the obtained probabilities of importation conditional to the reported travel destinations allows for a better quantification of importation in elimination districts. Second, preventing importation, either by testing and treating travelers or by reducing malaria transmission in Inhambane, might be especially relevant to eliminate malaria in Matutuine district. These efforts would be more cost-efficient during the dry season when importation rates are higher. These interventions could potentially target around 60% of the infections in Matutuine, given that 60.9% of the studied cases are genetically more related to Inhambane than to Maputo. However, a better understanding of transmission networks is needed to quantify the real impact of importation on the overall transmission. Finally, targeting the whole population through vector control or mass drug administrations (MDAs) may be more appropriate in areas such as Magude where importation rates are low. In both districts, reactive strategies targeting remaining infections will be needed to interrupt transmission<sup><xref ref-type="bibr" rid="c47">47</xref></sup>.</p>
<p>While these results propose programmatic strategies for the two study districts, routine surveillance to detect importation in Mozambique would allow for identifying new strategies in other districts aiming for elimination, as well as monitoring changes in importation rates in Magude and Matutuine in the future. If scaling molecular surveillance is not feasible, travel reports could be integrated in the routing surveillance to extrapolate the case classification based on the results of this study. In general, the method presented here can be applied to other <italic>P. falciparum</italic> endemic areas, as well as to <italic>P. vivax</italic> endemic areas outside Africa. For the case of <italic>P. vivax</italic>, symptomatic cases are not necessarily reflecting recent infections, so that travel reports might need to cover longer time periods, which does not require any essential adaptation to the method. We added this text to the discussion.</p>
<p>The study presents some limitations. First, except in Magude and Matutuine, <italic>P. falciparum</italic> isolates in the rest of the country were collected at selected health facilities and therefore may not be representative of the whole parasite population circulating in Mozambique, potentially biasing genetic relatedness with respect to Maputo province and potentially overestimating the genetic differentiation and underestimating importation. In particular, in Nampula, the province with the highest genetic relatedness, the sampling was conducted within 2 weeks in January and at only one health facility per district. Also, assuming that the samples from each province are representative of the travel destinations of the study cases might underestimate importation. However, the impact on our results must be small due to the high importation rates obtained. Second, only 25.6% (207/809) of the index cases were included in the importation analysis due to the low completeness of metadata. Third, our proxy of malaria transmission intensity was based on mRDT positivity rates in children under 5 years from a household-based survey, which is optimal for estimating malaria burden but not for transmission intensity. Better proxies of transmission intensity could be malaria incidence at the monthly level from national surveillance systems, or estimates of force of infection, for example from the use of molecular longitudinal data if available. Also, importation probabilities relied on travel reports and were sensitive to their potential biases (e.g. unreported travels). Finally, seasonality of malaria transmission was not taken into account in the modelling of importation probabilities, which could increase the precision of the estimates. Future studies will use increased sample sizes and cluster sampling approaches, as well as refined modelling of malaria incidence, to address all these limitations.</p>
<p>To conclude, a new Bayesian model was used combining epidemiological, mobility and genetic data simultaneously to provide individual case classification, which potentially allow for identifying individual factors and specific populations for fine targeted approaches for elimination. Both mobility and genetic data were found to be informative of importation, highlighting the potential of malaria genomics to refine importation estimates. Very distinct importation and travel rates were found in two close districts with very similar malaria burden. The main sources of transmission were identified in these low-transmission areas that can inform decision-making strategies for malaria elimination.</p>
</sec>
<sec id="s4">
<title>Methods</title>
<sec id="s4a">
<title>Study design and sample collection</title>
<p>In Magude and Matutuine districts, all clinical cases who tested positive for malaria using HRP2-based rapid diagnostic tests (Bioline Malaria Ag <italic>P.f.</italic>, 05FK50 [Abbott], First Response® Malaria Antigen <italic>P. falciparum</italic> HRP2 [Premier Medical], AdvDxTM Malaria <italic>Pf</italic> Rapid Malaria Ag Detection Test [Advy]) during 2022 were invited to participate in the study if they were older than 6 months, resided in the area and had no symptoms of severe malaria. For all participants giving consent (by their adult representative for minors), forms were filled out to collect demographic and epidemiological information, including their travel times and destinations within the past 28 days. The RDTs were labeled with patient ID codes, placed in zip-lock plastic bags containing silica gel, and shipped to CISM where they were stored at -20°C until further processing.</p>
<p>A convenience sampling approach was conducted at selected health facilities in 9 provinces during the rainy season (January to May) of 2022<sup><xref ref-type="bibr" rid="c38">38</xref>,<xref ref-type="bibr" rid="c40">40</xref></sup>: Maputo (including Maputo city; all ages &gt;6 months); Inhambane, Manica, Zambézia, Sofala and Manica (children 2-10 years old); Nampula (children 3 months-5 years old); and Tete and Cabo Delgado (children 6 months-5 years old) (Suppl. Fig. 1). For all surveys, inclusion criteria were confirmed diagnosis of uncomplicated malaria by routine RDT, providing informed consent (participant or adult representative). For Tete and Cabo Delgado an additional criteria of parasite density &gt;1000 parasites/μL was applied. Once consent was given, two to four 50𝜇L dried blood spots (DBS) were prepared onto one or two filter papers through finger prick. DBS were identified with anonymous barcodes, air-dried, packed with silica gel and stored at 4°C until shipment to CISM, where sealed bags were kept at -20°C in the central laboratory until processing. The number of successfully sequenced samples per province ranged from 78 to 364, being the highest N for Inhambane province, the most frequent travel destination of the study cases (Suppl. Table 2). All samples were shipped to ISGlobal (Barcelona) for sample processing.</p>
</sec>
<sec id="s4b">
<title>Genomic DNA extraction and quantification</title>
<p>Genomic DNA was extracted from RDT strips or from DBS samples using a Tween-Chelex based protocol<sup><xref ref-type="bibr" rid="c39">39</xref></sup> (see Supplementary methods). <italic>P. falciparum</italic> infection was confirmed in all DNA samples by qPCR targeting the 18S rRNA gene on an ABI PRISM 7500 HT Real-Time System (Applied Biosystems), as previously described<sup><xref ref-type="bibr" rid="c48">48</xref></sup>. Parasite density was quantified by extrapolation to an external standard curve composed of six 1:10 dilutions of 3D7 cultured parasites in whole blood (range 1 to 100,000 parasites/µl; MRA-151, MR4, Bei Resources). DNA was stored at -20°C until sequencing.</p>
</sec>
<sec id="s4c">
<title>Amplicon-based sequencing and sequence data analysis</title>
<p>Sequencing was performed using the MAD<sup>4</sup>HatTeR multiplex amplicon sequencing panel as previously described<sup><xref ref-type="bibr" rid="c38">38</xref>,<xref ref-type="bibr" rid="c39">39</xref></sup> (Supplementary methods). FASTQ files were subjected to filtering, demultiplexing and allele inference using MAD<sup>4</sup>HatTeR Nextflow-based pipeline version 0.1.8 (<ext-link ext-link-type="uri" xlink:href="https://github.com/EPPIcenter/mad4hatter">https://github.com/EPPIcenter/mad4hatter</ext-link>)<sup><xref ref-type="bibr" rid="c41">41</xref></sup>. The 3D7 genome sequence was used as reference for alternative allele calling (<ext-link ext-link-type="uri" xlink:href="https://github.com/EPPIcenter/mad4hatter/blob/main/resources/v4/ALL_refseq.fa">https://github.com/EPPIcenter/mad4hatter/blob/main/resources/v4/ALL_refseq.fa</ext-link>). The resulting allele tables were subsequently filtered based on read counts and coverage across loci within a sample and across samples. Alleles with fewer reads than the maximum observed reads in any locus for negative controls were removed, along with alleles with &lt;1% within-sample frequency.</p>
<p>For this analysis, the 165 loci of diversity from MAD<sup>4</sup>HatTeR D1 pool were used. Samples with less than 50 loci covered with a minimum of 100 reads were excluded. The exclusion criteria for loci was defined as those with less than 100 samples covering at least 100 reads.</p>
<p>Intra-host COI, eCOI and polyclonal probability were obtained using MOIRE v3.4.0<sup><xref ref-type="bibr" rid="c49">49</xref></sup> (<ext-link ext-link-type="uri" xlink:href="https://github.com/EPPIcenter/moire">https://github.com/EPPIcenter/moire</ext-link>), which uses a Monte Carlo Markov Chain (MCMC) approach taking into account intra-host relatedness and allele frequencies at the population level. MOIRE was run taking all samples as one populations, but no significant differences were found when run across different regions. Naive polyclonality was defined as COI&gt;1, and polyclonality as eCOI&gt;1.1. Genetic diversity was estimated as IBD using Dcifer 1.2.0<sup><xref ref-type="bibr" rid="c50">50</xref></sup> (<ext-link ext-link-type="uri" xlink:href="https://eppicenter.github.io/dcifer/">https://eppicenter.github.io/dcifer/</ext-link>), which takes into account polyclonal infections and their intra-host relatedness to infer IBD across sample pairs. Dcifer provides an estimate of IBD as well as a p-value of rejecting IBD&gt;0. In the analysis, sample pairs were defined as IBD-related if IBD&gt;0.1 (higher thresholds implied lower statistics of related pairs) with p&lt;0.05 (rejecting IBD=0), and the genetic relatedness, <italic>R</italic>, between two populations (or within a population) was defined as the fraction of IBD-related pairs between (or within) populations (equivalent trends were found for different IBD thresholds).</p>
</sec>
<sec id="s4d">
<title>Statistical analysis</title>
<p>IBD analysis was conducted across provinces and across regions, defining regions as south (Maputo, Inhambane and Gaza), centre (Manica, Sofala, Tete and Zambézia) and north (Nampula, Niassa and Cabo Delgado). The statistical significance of <italic>R</italic> between (and within) populations was calculated as their difference with respect to the average <italic>R</italic> across the whole population. The p-value was calculated from bootstrap resampling with replacement, assuming no spatial differentiation.</p>
<p>Spatial structure of <italic>R</italic> (using IBD thresholds of 0.1, 0.15 and 0.2) was studied as a function of the pairwise geographical distance, using different distance ranges (100-1,400 km, 10-100 km and 0-10 km), with binning balancing spatial granularity with sample size. The statistical trends were obtained from a logistic regression of <italic>R</italic> versus distance, with a p-value of rejecting no dependence.</p>
<p>A new Bayesian approach was used to infer probabilities of importation combining epidemiological, genetic and mobility data. The approach models the probability of being infected (<italic>I</italic>) for <italic>P. falciparum</italic> in an area (<italic>A</italic>) given the <italic>P. falciparum</italic> genome (<italic>G</italic>) of the infection as:
<disp-formula id="disp-eqn-1">
<graphic xlink:href="25326793v3_ueqn1.gif" mimetype="image" mime-subtype="gif"/>
</disp-formula>
Where 𝑃(𝐼<sub>𝐴</sub>| 𝐺) is the probability of being infected in area <italic>A</italic> given a <italic>P. falciparum</italic> genome <italic>G</italic>, 𝑃(𝐺 | 𝐼 <sub>𝐴</sub> ) is the probability of having a <italic>P. falciparum</italic> genome <italic>G</italic> if the infection occurred in area <italic>A</italic>, and 𝑃(𝐼 <sub>𝐴</sub>) and 𝑃(𝐺) are the probabilities of being infected in area <italic>A</italic> and having <italic>P. falciparum</italic> genome <italic>G</italic> respectively. To estimate 𝑃(𝐼<sub>𝐴</sub>), it was assumed that the probability of an infection to have occurred in a province is proportional to a) the time spent in that province, and b) the transmission intensity of that province:
<disp-formula id="disp-eqn-2">
<graphic xlink:href="25326793v3_ueqn2.gif" mimetype="image" mime-subtype="gif"/>
</disp-formula>
Where <italic>T<sub>A</sub></italic> is the time spent in area <italic>A</italic>, <italic>PR<sub>A</sub></italic> is (a proxy of) the transmission intensity in <italic>A</italic> and <italic>K</italic> is an unknown constant that does not depend on the specific area, assuming that the differences in transmission intensity were captured in <italic>PR</italic> (Suppl. Importation analysis). 𝑃(𝐺 | 𝐼<sub>𝐴</sub> ) was estimated as <italic>R’<sub>A</sub></italic> , defined as the fraction of samples from <italic>A</italic> that are IBD-related to the sample studied. With the constraint that 𝑃(𝐼<sub>𝐴</sub>| 𝐺) + 𝑃(𝐼<sub>𝐵</sub> | 𝐺) = 1 if the case had only stayed in two areas recently (as the study cases), 𝑃(𝐼 ) becomes:
<disp-formula id="disp-eqn-3">
<graphic xlink:href="25326793v3_ueqn3.gif" mimetype="image" mime-subtype="gif"/>
</disp-formula>
The probability of being imported was obtained defining <italic>A</italic> as the travel destination area and <italic>B</italic> as the local area (Maputo province). Assuming that the infection did not occur earlier than the past 28 days, a case was considered locally transmitted if it reported no travels in the last 28 days. The infection was assumed to take at least 7 days to become symptomatic, so <italic>T<sub>A</sub></italic> and <italic>T<sub>B</sub></italic>were obtained from the last 7 to 28 days. For missing travel durations, the average <italic>T</italic> of all available data was imputed, corresponding to 9.14 days. <italic>PR<sub>A,B</sub></italic> were estimated from the mRDT positivity rates (PR<sub>RDT</sub>) per province in children reported in the last Health Demographic Survey 2022-2023 from Mozambique<sup><xref ref-type="bibr" rid="c42">42</xref></sup>. Since the PR<sub>RDT</sub> in Maputo City was rounded as 0.0, a value of 0.04 was assumed, probably overestimating (with negligible impact) the infection probabilities in Maputo City. <italic>R’<sub>A,B</sub></italic> was estimated as the fraction of samples from the area (province) that were IBD-related (IBD&gt;0.1, p&lt;0.05) with the sample studied. When estimating <italic>R’</italic> with Maputo province, one could consider excluding the samples from clinical cases reporting trips to avoid biases from imported cases. The impact of this choice was lower than 1% in the estimated imported rates, so all cases were included to estimate <italic>R’</italic>, a more conservative approach that was also more consistent with the other provinces where no travel reports were available. For missing <italic>R’</italic> estimates, such as in Gaza province, only <italic>T</italic> and <italic>PR</italic> factors were used to estimate probabilities of importation. Cases were classified as imported for importation probabilities higher than 50%, and as local otherwise. Importation rates were obtained from the fraction of imported cases over all classified cases. Similar rates were obtained using weighted sums of individual probabilities given the extreme values of probabilities obtained (<xref rid="fig4" ref-type="fig">Fig. 4</xref>, <xref rid="tbl2" ref-type="table">Table 2</xref>). In case of obtaining a higher fraction of intermediate values (0.4-0.6), weighted sums of individual probabilities would be more appropriate to better quantify importation rates.</p>
<p>The correlation between travel reports and genetic relatedness was quantified from the fraction of cases reporting (or not) a travel in a given province and their fraction of cases that were more related to the origin and travel destination populations, conducting a chi square test for independence under the assumption that the probabilities of being more related to an area than to Maputo province were not correlated with travels reported.</p>
<p>Risk-factor analyses were conducted using firth logistic regression to identify factors associated with importation and travel. The analysis included the following characteristics: district of residence (Magude or Matutuine), seasonality (defined as rainy for cases reported from January to May and dry for cases from June to December), sex, pregnancy, occupation, age (stratified as adults and minors) and province of travel destination. In order to assess the potential of molecular data to inform about imported cases, the same analysis was done including parasite density, eCOI and polyclonality. Since imported cases required a travel report by definition, the same factor analysis on importation was conducted restricted to those cases with travel reports (this time including travel destination in the multivariate analysis). Odds ratios and p-values were obtained from the firth logistic regressions in a univariate analysis and also in a multivariate analysis using all factors without interactions (the limited sample sizes did not allow for exploring interactions between factors).</p>
<p>All over the analysis, statistical significance was defined as p&lt;0.05. All the analyses were performed using Python 3.9.16, Jupyter Lab 3.3.2 and R 4.2.3.</p>
</sec>
<sec id="s4e" sec-type="ethics-statement">
<title>Ethical considerations</title>
<p>This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. Ethical approval was obtained from the Comité Nacional de Bioética para Saúde (CNBS) Mozambique, affiliated with the Ministério de Saúde (approval number 604/CNBS/21; 1st November 2023). The CNBS can be contacted at: Ministério de Saúde - 2° andar dto, Av. Eduardo Mondlane / Salvador Allende, PC 264, Maputo, Mozambique.</p>
</sec>
</sec>

</body>
<back>
<sec id="das" sec-type="data-availability">
<title>Data availability</title>
<p>Sequencing data is available at NCBI Sequence Read Archive (SRA) under BioProject accession codes PRJNA1107381 (BioSamples SAMN41181143-SAMN41181403, SAMN41181489-SAMN41181607, SAMN41181678- SAMN41182039 and SAMN41180171-SAMN41180265) and PRJNA1287343 (BioSamples SAMN49839130-SAMN49839420).</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We would like to thank all the individuals of the study and their corresponding parents/guardians who agreed to participate in the study, clinical officers, field supervisors, data managers and lab technicians from all participating institutions. We thank Llorenç Quintó for his advice on statistical analysis. This work was supported financially by the Bill and Melinda Gates Foundation (INV-019032, A.M. and INV-067310, A.M.), the Government of Catalonia and co-financed by the European Social Fund of the EU (Agència de Gestió d’Ajuts Universitaris i de Recerca [AGAUR] grant 2022 FI_B 00148, S.B. and SGR 01517 to A.M.), the European Union’s Horizon 2020 research and innovation programme (Marie Skłodowska-Curie grant 890477, A.P.). The project that gave rise to these results received the support of a fellowship from the ”laCaixa” Foundation (ID 100010434). The fellowship code is LCF/BQ/PR24/12050009 (A.P.). The Centro de Investigação em Saúde de Manhiça (CISM) is supported by the Government of Mozambique and the Spanish Agency for International Development Cooperation (AECID). This research is part of ISGlobal’s Program on the Molecular Mechanisms of Malaria which is partially supported by the Fundación Ramón Areces. We acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/10.13039/501100011033, and from the Generalitat de Catalunya through the CERCA Program. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.</p>
</ack>
<sec id="additional-info" sec-type="additional-information">
<title>Additional information</title>
<sec id="s6">
<title>Code availability</title>
<p>All code used in the analysis is open source under a GNU General Public License. The main open source repository of this analysis can be accessed here: <ext-link ext-link-type="uri" xlink:href="https://github.com/MalPhyGen/malaria_relatedness_importation">https://github.com/MalPhyGen/malaria_relatedness_importation</ext-link>. The repository contains software requirements and installation instructions, with references to other public repositories used, and demos of the whole analyses conducted.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>A.P., A.C. drafted the manuscript and led the data analysis and interpretation of the results. C.dS., S.B., H.Mv., D.T., J.I., P.C., C.G.F., A.V.B. processed the samples and analysed the data. A.A.D. led the design of the sequencing panel and data processing. M.G.U. contributed to the bioinformatic pipeline and analysis for data processing and replicated the results of the analysis. E.R.V., A.M., B.G., A.A.D., M.M. contributed to the discussion and interpretation of results. C.G., S.M.E., F.S., P.A., B.C., A.M., B.R., E.R.V. participated in the study design. H.Mu., F.L., C.dS., L.N., W.S., N.C., A.C., G.M., N.N., M.T., J.M., L.F.S., K.U.B. coordinated the field work and data collection. All authors critically revised the manuscript, had full access to the data used in the study, and accepted the responsibility to submit it for publication.</p>
</sec>
</sec>
<sec id="additional-files" sec-type="supplementary-material">
<title>Additional files</title>
<supplementary-material id="supp1">
<label>Supplementary Informaton</label>
<media xlink:href="supplements/326793_file02.pdf"/>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Deng</surname>, <given-names>C.</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Large-scale Artemisinin-Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa</article-title>. <source>Clin Infect Dis</source> <volume>67</volume>, <fpage>1670</fpage>–<lpage>1676</lpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mwesigwa</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Mass Drug Administration With Dihydroartemisinin-piperaquine and Malaria Transmission Dynamics in The Gambia: A Prospective Cohort Study</article-title>. <source>Clin Infect Dis</source> <volume>69</volume>, <fpage>278</fpage>–<lpage>286</lpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Molineaux</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Gramiccia</surname>, <given-names>G.</given-names></string-name></person-group> <source>The Garki Project. Research on the epidemiology and control of malaria in the Sudan savanna of West Africa</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>. (<year>1980</year>).</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eisele</surname>, <given-names>T. P.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Short-term Impact of Mass Drug Administration With Dihydroartemisinin Plus Piperaquine on Malaria in Southern Province Zambia: A Cluster-Randomized Controlled Trial</article-title>. <source>J Infect Dis</source> <volume>214</volume>, <fpage>1831</fpage>–<lpage>1839</lpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ali</surname>, <given-names>A. S.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar</article-title>. <source>Malar J</source> <volume>16</volume>, <fpage>332</fpage> (<year>2017</year>).</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Galatas</surname>, <given-names>B.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>A multiphase program for malaria elimination in southern Mozambique (the Magude project): A before-after study</article-title>. <source>PLoS Med</source> <volume>17</volume>, <fpage>e1003227</fpage> (<year>2020</year>).</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ohrt</surname>, <given-names>C.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Information systems to support surveillance for malaria elimination</article-title>. <source>Am J Trop Med Hyg</source> <volume>93</volume>, <fpage>145</fpage>–<lpage>152</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stresman</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Bousema</surname>, <given-names>T.</given-names></string-name> &amp; <string-name><surname>Cook</surname>, <given-names>J</given-names></string-name></person-group>. <article-title>Malaria Hotspots: Is There Epidemiological Evidence for Fine-Scale Spatial Targeting of Interventions?</article-title> <source>Trends in Parasitology</source> <volume>35</volume>, <fpage>822</fpage>–<lpage>834</lpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cotter</surname>, <given-names>C.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>The changing epidemiology of malaria elimination: new strategies for new challenges</article-title>. <source>Lancet</source> <volume>382</volume>, <fpage>900</fpage>–<lpage>911</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guerra</surname>, <given-names>C. A.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Human mobility patterns and malaria importation on Bioko Island</article-title>. <source>Nat Commun</source> <volume>10</volume>, <fpage>2332</fpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Arisco</surname>, <given-names>N. J.</given-names></string-name>, <string-name><surname>Peterka</surname>, <given-names>C.</given-names></string-name> &amp; <string-name><surname>Castro</surname>, <given-names>M. C</given-names></string-name></person-group>. <article-title>Imported malaria definition and minimum data for surveillance</article-title>. <source>Sci Rep</source> <volume>12</volume>, <fpage>17982</fpage> (<year>2022</year>).</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Le Menach</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Travel risk, malaria importation and malaria transmission in Zanzibar</article-title>. <source>Sci Rep</source> <volume>1</volume>, <fpage>93</fpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wangdi</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Gatton</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Kelly</surname>, <given-names>G. C.</given-names></string-name> &amp; <string-name><surname>Clements</surname>, <given-names>A. C. A</given-names></string-name></person-group>. <article-title>Cross-border malaria: a major obstacle for malaria elimination</article-title>. <source>Adv Parasitol</source> <volume>89</volume>, <fpage>79</fpage>–<lpage>107</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dalmat</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Naughton</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Kwan-Gett</surname>, <given-names>T. S.</given-names></string-name>, <string-name><surname>Slyker</surname>, <given-names>J.</given-names></string-name> &amp; <string-name><surname>Stuckey</surname>, <given-names>E. M</given-names></string-name></person-group>. <article-title>Use cases for genetic epidemiology in malaria elimination</article-title>. <source>Malar J</source> <volume>18</volume>, <fpage>163</fpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ferriss</surname>, <given-names>E.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Malaria Transmission at The Zimbabwe-Mozambique Border: An Observational Study of Parasitemia by Travel History and Household Location</article-title>. <source>Am J Trop Med Hyg</source> <volume>111</volume>, <fpage>35</fpage>–<lpage>42</lpage> (<year>2024</year>).</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Markwalter</surname>, <given-names>C. F.</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Plasmodium falciparum importation does not sustain malaria transmission in a semi-arid region of Kenya</article-title>. <source>PLOS Glob Public Health</source> <volume>2</volume>, <fpage>e0000807</fpage> (<year>2022</year>).</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tam</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Cowling</surname>, <given-names>B. J.</given-names></string-name> &amp; <string-name><surname>Maude</surname>, <given-names>R. J</given-names></string-name></person-group>. <article-title>Analysing human population movement data for malaria control and elimination</article-title>. <source>Malar J</source> <volume>20</volume>, <fpage>294</fpage> (<year>2021</year>).</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Roh</surname>, <given-names>M. E.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>High Genetic Diversity of Plasmodium falciparum in the Low-Transmission Setting of the Kingdom of Eswatini</article-title>. <source>J Infect Dis</source> <volume>220</volume>, <fpage>1346</fpage>–<lpage>1354</lpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Arisco</surname>, <given-names>N. J.</given-names></string-name>, <string-name><surname>Peterka</surname>, <given-names>C.</given-names></string-name> &amp; <string-name><surname>Castro</surname>, <given-names>M. C.</given-names></string-name></person-group> <article-title>Spatiotemporal analysis of within-country imported malaria in Brazilian municipalities, 2004-2022</article-title>. <source>PLOS Glob Public Health</source> <volume>4</volume>, <fpage>e0003452</fpage> (<year>2024</year>).</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ihantamalala</surname>, <given-names>F. A.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Estimating sources and sinks of malaria parasites in Madagascar</article-title>. <source>Nat Commun</source> <volume>9</volume>, <fpage>3897</fpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chang</surname>, <given-names>H.-H.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Mapping imported malaria in Bangladesh using parasite genetic and human mobility data</article-title>. <source>eLife</source> <volume>8</volume>, <elocation-id>e43481</elocation-id> (<year>2019</year>). <pub-id pub-id-type="doi">10.7554/eLife.43481</pub-id></mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wesolowski</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Quantifying the impact of human mobility on malaria</article-title>. <source>Science</source> <volume>338</volume>, <fpage>267</fpage>–<lpage>270</lpage> (<year>2012</year>).</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="preprint"><person-group person-group-type="author"><string-name><surname>Chen</surname>, <given-names>Y.-A.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Genetic surveillance reveals low, sustained malaria transmission with clonal replacement in Sao Tome and Principe</article-title>. <source>medRxiv</source> 2024.07.15.24309968 (<year>2024</year>) doi:<pub-id pub-id-type="doi">10.1101/2024.07.15.24309968</pub-id>.</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="preprint"><person-group person-group-type="author"><string-name><surname>Safarpour</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Detecting imported malaria infections in endemic settings using 2 molecular surveillance: current state and challenges</article-title>. <source>MedRxiv</source> <year>2024</year>. doi: <pub-id pub-id-type="doi">10.1101/2024.09.09.24313136</pub-id>.</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shetty</surname>, <given-names>A. C.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Genomic structure and diversity of Plasmodium falciparum in Southeast Asia reveal recent parasite migration patterns</article-title>. <source>Nat Commun</source> <volume>10</volume>, <fpage>2665</fpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Taylor</surname>, <given-names>A. R.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Quantifying connectivity between local Plasmodium falciparum malaria parasite populations using identity by descent</article-title>. <source>PLOS Genetics</source> <volume>13</volume>, <fpage>e1007065</fpage> (<year>2017</year>).</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hubbard</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Implementing landscape genetics in molecular epidemiology to determine drivers of vector-borne disease: A malaria case study</article-title>. <source>Molecular Ecology</source> <volume>32</volume>, <fpage>1848</fpage>–<lpage>1859</lpage> (<year>2023</year>).</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>, <given-names>Y.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Detecting geospatial patterns of Plasmodium falciparum parasite migration in Cambodia using optimized estimated effective migration surfaces</article-title>. <source>International Journal of Health Geographics</source> <volume>19</volume>, <fpage>13</fpage> (<year>2020</year>).</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brown</surname>, <given-names>T. S.</given-names></string-name>, <string-name><surname>Arogbokun</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Buckee</surname>, <given-names>C. O.</given-names></string-name> &amp; <string-name><surname>Chang</surname>, <given-names>H.-H</given-names></string-name></person-group>. <article-title>Distinguishing gene flow between malaria parasite populations</article-title>. <source>PLoS Genet</source> <volume>17</volume>, <fpage>e1009335</fpage> (<year>2021</year>).</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tessema</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Using parasite genetic and human mobility data to infer local and cross-border malaria connectivity in Southern Africa</article-title>. <source>eLife</source> <volume>8</volume>, <elocation-id>e43510</elocation-id> (<year>2019</year>). <pub-id pub-id-type="doi">10.7554/eLife.43510</pub-id></mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lo</surname>, <given-names>E.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes</article-title>. <source>PLoS Negl Trop Dis</source> <volume>11</volume>, <fpage>e0005806</fpage> (<year>2017</year>).</mixed-citation></ref>
    <ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fola</surname>, <given-names>A. A.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Nationwide genetic surveillance of <italic>Plasmodium vivax</italic> in Papua New Guinea reveals heterogeneous transmission dynamics and routes of migration amongst subdivided populations</article-title>, <source>Infection, Genetics and Evolution</source> <volume>58</volume>, <fpage>83</fpage>–<lpage>95</lpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sekine</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Tracing the origins of Plasmodium vivax resurgence after malaria elimination on Aneityum Island in Vanuatu</article-title>. <source>Commun Med</source> <volume>4</volume>, <issue>91</issue> (<year>2024</year>).</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Delgado-Ratto</surname>, <given-names>C.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Population Genetics of Plasmodium vivax in the Peruvian Amazon</article-title>. <source>PLoS Negl Trop Dis</source> <volume>10</volume>, <fpage>e0004376</fpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ventocilla</surname>, <given-names>J. A.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Genetic Variability of Plasmodium vivax in the North Coast of Peru and the Ecuadorian Amazon Basin</article-title>. <source>Am J Trop Med Hyg</source> <volume>99</volume>, <fpage>27</fpage>–<lpage>32</lpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Phelan</surname>, <given-names>J. E.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Rapid profiling of Plasmodium parasites from genome sequences to assist malaria control</article-title>. <source>Genome Med</source> <volume>15</volume>, <fpage>96</fpage> (<year>2023</year>).</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Valdivia</surname>, <given-names>H. O.</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Genomic surveillance of Plasmodium falciparum and Plasmodium vivax cases at the University Hospital in Tegucigalpa, Honduras</article-title>. <source>Sci Rep</source> <volume>10</volume>, <fpage>20975</fpage> (<year>2020</year>).</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="preprint"><person-group person-group-type="author"><string-name><surname>Boene</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Antimalarial drug resistance and population structure of Plasmodium falciparum in Mozambique using genomic surveillance at health facilities (2021-2022)</article-title> | <source>VeriXiv</source>. <ext-link ext-link-type="uri" xlink:href="https://verixiv.org/articles/1-31/v1">https://verixiv.org/articles/1-31/v1</ext-link> <year>2024</year></mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brokhattingen</surname>, <given-names>N.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Genomic malaria surveillance of antenatal care users detects reduced transmission following elimination interventions in Mozambique</article-title>. <source>Nat Commun</source> <volume>15</volume>, <fpage>2402</fpage> (<year>2024</year>).</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mayor</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Prospective surveillance study to detect antimalarial drug resistance, gene deletions of diagnostic relevance and genetic diversity of Plasmodium falciparum in Mozambique: protocol</article-title>. <source>BMJ Open</source> <volume>12</volume>, <fpage>e063456</fpage> (<year>2022</year>).</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="preprint"><person-group person-group-type="author"><string-name><surname>Aranda-Díaz</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Sensitive and modular amplicon sequencing of Plasmodium falciparum diversity and resistance for research and public health</article-title>. <source>bioRxiv</source> 2024.08.22.609145 (<year>2024</year>) doi:<pub-id pub-id-type="doi">10.1101/2024.08.22.609145</pub-id>.</mixed-citation></ref>
    <ref id="c42"><label>42.</label><mixed-citation publication-type="report"><person-group person-group-type="author"><collab>ICF International</collab> <collab>National Institute of Statistics (INE) (Mozambique)</collab></person-group>. <source>Mozambique Demographic and Health Survey 2022-2023</source>: <publisher-loc>Fairfax, United States</publisher-loc><publisher-name>ICF International</publisher-name>, <year>2024</year>.</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Firth</surname>, <given-names>D</given-names></string-name></person-group>. <article-title>Bias reduction of maximum likelihood estimates</article-title>. <source>Biometrika</source> <volume>80</volume>, <fpage>27</fpage>–<lpage>38</lpage> (<year>1993</year>).</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>da Silva</surname>, <given-names>C.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Plasmodium falciparum molecular surveillance to inform the Mozambican National Malaria Control Programme strategy: protocol</article-title>. <source>BMJ Open</source> <volume>14</volume>, <fpage>e092590</fpage> (<year>2024</year>).</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="preprint"><person-group person-group-type="author"><string-name><surname>Wong</surname>, <given-names>W.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Evaluating the performance of Plasmodium falciparum genetics for inferring National Malaria Control Program reported incidence in Senegal</article-title>. <source>Res Sq</source> (<year>2023</year>) doi:<pub-id pub-id-type="doi">10.21203/rs.3.rs-3516287/v1</pub-id>.</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huber</surname>, <given-names>J. H.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Inferring person-to-person networks of Plasmodium falciparum transmission: are analyses of routine surveillance data up to the task?</article-title> <source>Malar J</source> <volume>21</volume>, <fpage>58</fpage> (<year>2022</year>).</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aidoo</surname>, <given-names>E. K.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Reactive Case Detection Strategy for Malaria Control and Elimination: A 12 Year Systematic Review and Meta-Analysis from 25 Malaria-Endemic Countries</article-title>. <source>Trop Med Infect Dis</source> <volume>8</volume>, <fpage>180</fpage> (<year>2023</year>).</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mayor</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>How hidden can malaria be in pregnant women? Diagnosis by microscopy, placental histology, polymerase chain reaction and detection of histidine-rich protein 2 in plasma</article-title>. <source>Clin Infect Dis</source> <volume>54</volume>, <fpage>1561</fpage>–<lpage>1568</lpage> (<year>2012</year>).</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Murphy</surname>, <given-names>M.</given-names></string-name> &amp; <string-name><surname>Greenhouse</surname>, <given-names>B</given-names></string-name></person-group>. <article-title>MOIRE: a software package for the estimation of allele frequencies and effective multiplicity of infection from polyallelic data</article-title>. <source>Bioinformatics</source> <volume>40</volume>, <fpage>btae619</fpage> (<year>2024</year>).</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gerlovina</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Gerlovin</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Rodríguez-Barraquer</surname>, <given-names>I.</given-names></string-name> &amp; <string-name><surname>Greenhouse</surname>, <given-names>B</given-names></string-name></person-group>. <article-title>Dcifer: an IBD-based method to calculate genetic distance between polyclonal infections</article-title>. <source>Genetics</source> <volume>222</volume>, <fpage>iyac126</fpage> (<year>2022</year>).</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107136.2.sa4</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ferreira</surname>
<given-names>Marcelo U</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of São Paulo</institution>
</institution-wrap>
<city>São Paulo</city>
<country>Brazil</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Convincing</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Important</kwd>
</kwd-group>
</front-stub>
<body>
<p>The authors present an <bold>important</bold> approach to identify imported P. falciparum malaria cases, combining genetic and epidemiological/travel data. This tool has the potential to be expanded to other contexts. The data was analyzed using <bold>convincing</bold> methods, including a novel statistical model. This study may be of interest to researchers in public health and infectious diseases beyond malaria.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107136.2.sa3</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>This study presents a new Bayesian approach to estimate importation probabilities of malaria combining epidemiological data, travel history, and genetic data through pairwise IBD estimates. Importation is an important factor challenging malaria elimination, especially in low transmission settings. This paper focus on Magude and Matutuine, two districts in south Mozambique with very low malaria transmission. The results show isolation-by-distance in Mozambique, with genetic relatedness decreasing with distances larger than 100 km, and no spatial correlation for distances between 10 and 100 km. But again strong spatial correlation in distances smaller than 10 km. They report high genetic relatedness between Matutuine and Inhambane, higher than between Matutuine and Magude. Inhambane is the main source of importation in Matutuine, accounting for 63.5% of imported cases. Magude, on the other hand, shows smaller importation and travel rates than Matutuine, as it is a rural area with less mobility. Additionally, they report higher levels of importation and travel in the dry season, when transmission is lower. Also, no association with importation was found for occupation, sex and other factors. These data have practical implications for public health strategies aiming malaria elimination, for example, testing and treating travelers from Matutuine in the dry season.</p>
<p>Strengths:</p>
<p>The strength of this study relies in the combination of different sources of data - epidemiological, travel and genetic data - to estimate importation probabilities, the statistical analyses.</p>
<p>Weaknesses:</p>
<p>The authors recognize the limitations related to sample size and the biases of travel reports.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107136.2.sa2</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>Based on a detailed dataset, the authors present a novel Bayesian approach to classify malaria cases as either imported or locally acquired.</p>
<p>Strengths:</p>
<p>The proposed Bayesian approach for case classification is simple, well justified, and allows the integration of parasite genomics, travel history, and epidemiological data.</p>
<p>Weakness:</p>
<p>While the authors aim to classify cases as imported or locally acquired, the work lacks a quantification of the contribution of each case type to overall transmission.</p>
<p>Comments on revisions:</p>
<p>All my questions and concerns were satisfactorily addressed.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107136.2.sa1</article-id>
<title-group>
<article-title>Reviewer #3 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>This work provides a novel statistical model to identify imported malaria cases, which are an important challenge for elimination, particularly in low-transmission areas. This tool was applied in Plasmodium falciparum populations in Mozambique and determined differences in importation rates in 2 low-transmission districts in the South.</p>
<p>Strengths:</p>
<p>The study has several strengths, mainly the development of a novel Bayesian model that integrates genomic, epidemiological, and travel data to estimate importation probabilities. The results showed insights into malaria transmission dynamics, particularly identifying importation sources and differences in importation rates in Mozambique. Finally, the relevance of the findings is to suggest interventions focusing on the traveler population to support efforts for malaria elimination.</p>
<p>Weaknesses:</p>
<p>The study also has some limitations, although the authors have plans to address them. The sample collection was not representative of some provinces, and not all samples had sufficient metadata for the risk factor analysis. Additionally, the authors used a proxy for transmission intensity and assumed some other conditions to calculate the importation probability for specific scenarios. They plan to conduct a new sample collection and include monthly malaria incidence estimates in the future.</p>
<p>Comments on revisions:</p>
<p>- Delete &quot;We added this text to the discussion&quot; in line 302 (Discussion)</p>
<p>
- I recommend adding the plans to address limitations indicated in the Response to Reviewers document in the Discussion. This would really strengthen the limitation section.</p>
</body>
</sub-article>
<sub-article id="sa4" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107136.2.sa0</article-id>
<title-group>
<article-title>Author response:</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Pujol</surname>
<given-names>Arnau</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7288-6435</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Chidimatembue</surname>
<given-names>Arlindo</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>da Silva</surname>
<given-names>Clemente</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boene</surname>
<given-names>Simone</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mbeve</surname>
<given-names>Henriques</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cisteró</surname>
<given-names>Pau</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>García-Fernández</surname>
<given-names>Carla</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vañó-Boira</surname>
<given-names>Arnau</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tembisse</surname>
<given-names>Dário</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Inácio</surname>
<given-names>José</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matambisso</surname>
<given-names>Glória</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luis</surname>
<given-names>Fabião</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ndimande</surname>
<given-names>Nelo</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Munguambe</surname>
<given-names>Humberto</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nhamussua</surname>
<given-names>Lidia</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Simone</surname>
<given-names>Wilson</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aranda-Díaz</surname>
<given-names>Andrés</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0566-4901</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>García-Ulloa</surname>
<given-names>Manuel</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Canana</surname>
<given-names>Neide</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tusell</surname>
<given-names>Maria</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Montaña</surname>
<given-names>Júlia</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fuente-Soro</surname>
<given-names>Laura</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bapu</surname>
<given-names>Khalid Ussene</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Murphy</surname>
<given-names>Maxwell</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0332-4388</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Rafael</surname>
<given-names>Bernardete</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rovira-Vallbona</surname>
<given-names>Eduard</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guinovart</surname>
<given-names>Caterina</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Greenhouse</surname>
<given-names>Bryan</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0287-9111</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Enosse</surname>
<given-names>Sonia Maria</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saúte</surname>
<given-names>Francisco</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aide</surname>
<given-names>Pedro</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Candrinho</surname>
<given-names>Baltazar</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mayor</surname>
<given-names>Alfredo</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3890-2897</contrib-id></contrib>
</contrib-group>
</front-stub>
<body>
<p>The following is the authors’ response to the original reviews</p>
<disp-quote content-type="editor-comment">
<p><bold>Public Reviews:</bold></p>
<p><bold>Reviewer #1 (Public review):</bold></p>
<p>Summary:</p>
<p>This study presents a new Bayesian approach to estimate importation probabilities of malaria, combining epidemiological data, travel history, and genetic data through pairwise IBD estimates. Importation is an important factor challenging malaria elimination, especially in low-transmission settings. This paper focuses on Magude and Matutuine, two districts in southern Mozambique with very low malaria transmission. The results show isolation-by-distance in Mozambique, with genetic relatedness decreasing with distances larger than 100 km, and no spatial correlation for distances between 10 and 100 km. But again, strong spatial correlation in distances smaller than 10 km. They report high genetic relatedness between Matutuine and Inhambane, higher than between Matutuine and Magude. Inhambane is the main source of importation in Matutuine, accounting for 63.5% of imported cases. Magude, on the other hand, shows smaller importation and travel rates than Matutuine, as it is a rural area with less mobility. Additionally, they report higher levels of importation and travel in the dry season, when transmission is lower. Also, no association with importation was found for occupation, sex, and other factors. These data have practical implications for public health strategies aiming for malaria elimination, for example, testing and treating travelers from Matutuine in the dry season.</p>
<p>Strengths:</p>
<p>The strength of this study lies in the combination of different sources of data - epidemiological, travel, and genetic data - to estimate importation probabilities, and the statistical analyses.</p>
<p>Weaknesses:</p>
<p>The authors recognize the limitations related to sample size and the biases of travel reports.</p>
</disp-quote>
<p>We appreciate the review and comment about the manuscript.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Public review):</bold></p>
<p>Summary:</p>
<p>Based on a detailed dataset, the authors present a novel Bayesian approach to classify malaria cases as either imported or locally acquired.</p>
<p>Strengths:</p>
<p>The proposed Bayesian approach for case classification is simple, well justified, and allows the integration of parasite genomics, travel history, and epidemiological data. The work is well-written, very organized, and brings important contributions both to malaria control efforts in Mozambique and to the scientific community. Understanding the origin of cases is essential for designing more effective control measures and elimination strategies.</p>
<p>Weakness:</p>
<p>While the authors aim to classify cases as imported or locally acquired, the work lacks a quantification of the contribution of each case type to overall transmission.</p>
</disp-quote>
<p>The method presented here allows for classifying individual cases according to whether the infection occurred locally or was imported during a trip. By definition, it does not look to secondary infections after an importation event. Our next step is to conduct outbreak investigation to quantify the impact of importation events on the overall transmission, but this activity goes beyond the scope of this manuscript. We clarify this in the discussion section.</p>
<disp-quote content-type="editor-comment">
<p>The Bayesian rationale is sound and well justified; however, the formulation appears to present an inconsistency that is replicated in both the main text and the Supplementary Material.</p>
</disp-quote>
<p>Thank you for pointing out the inconsistency in the final formula. In fact, the final formula corresponds to <italic>P</italic>(<italic>IA | G</italic>), instead of <italic>P</italic>(<italic>IA</italic>), so:</p>
<disp-formula id="sa4equ1">
<graphic mime-subtype="jpg" xlink:href="elife-107136-sa4-equ1.jpg" mimetype="image"/>
</disp-formula>
<p>instead of</p>
<disp-formula id="sa4equ2">
<graphic mime-subtype="jpg" xlink:href="elife-107136-sa4-equ2.jpg" mimetype="image"/>
</disp-formula>
<p>We have now corrected this error in the new version of the manuscript.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #3 (Public review):</bold></p>
<p>The authors present an important approach to identify imported P. falciparum malaria cases, combining genetic and epidemiological/travel data. This tool has the potential to be expanded to other contexts. The data was analyzed using convincing methods, including a novel statistical model; although some recognized limitations can be improved. This study will be of interest to researchers in public health and infectious diseases.</p>
<p>Strengths:</p>
<p>The study has several strengths, mainly the development of a novel Bayesian model that integrates genomic, epidemiological, and travel data to estimate importation probabilities. The results showed insights into malaria transmission dynamics, particularly identifying importation sources and differences in importation rates in Mozambique. Finally, the relevance of the findings is to suggest interventions focusing on the traveler population to help efforts for malaria elimination.</p>
<p>Weaknesses:</p>
<p>The study also has some limitations. The sample collection was not representative of some provinces, and not all samples had sufficient metadata for risk factor analysis, which can also be affected by travel recall bias. Additionally, the authors used a proxy for transmission intensity and assumed some conditions for the genetic variable when calculating the importation probability for specific scenarios. The weaknesses were assessed by the authors.</p>
</disp-quote>
<p>We acknowledge the limitations commented by the reviewer. We have the following plans to address the limitations. We will repeat the study for our data collected in 2023, which this time contains a good representation of all the provinces of Mozambique, and completeness of the metadata collection was ensured by implementing a new protocol in January 2023. Regarding the proxy for transmission intensity, we will refine the model by integrating monthly estimates of malaria incidence (previously calibrated to address testing and reporting rates) from the DHIS2 data, taking also into account the date of the reported cases in the analysis.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewing Editor Comments:</bold></p>
<p>The reviewers have made specific suggestions that could improve the clarity and accuracy of this report.</p>
<p><bold>Reviewer #1 (Recommendations for the authors):</bold></p>
<p>(1) Abstract, lines 36, 37 and 38: &quot;Spatial genetic structure and connectivity were assessed using microhaplotype-based genetic relatedness (identity-by-descent) from 1605 P. falciparum samples collected (...)&quot;, but only 540 samples were successfully sequenced, therefore used in spatial genetic structure and connectivity analysis.</p>
</disp-quote>
<p>The 540 samples refer to those from Maputo province and are described in Fig. 1. The Spatial and connectivity analyses also included the samples from the rest of the provinces from the multi-cluster sampling scheme. Sample sizes from these provinces are described in Suppl. Table 2, and the total between them and the 540 samples from Maputo are the 1605 samples mentioned in the abstract. We specify this number in the caption of Sup. Fig. 4, and add it now into Fig. 3</p>
<disp-quote content-type="editor-comment">
<p>(2) In the Introduction, some epidemiological context about Magude and Matutuine could be added. It is only mentioned in the Discussion section (lines 265-269).</p>
</disp-quote>
<p>We have added some context about both districts in the introduction now.</p>
<disp-quote content-type="editor-comment">
<p>(3) In the Discussion, lines 241-244, could the lack of structure mean no barriers for gene flow due to high mobility in short distances? Maybe it could only be resolved with a large number of samples.</p>
</disp-quote>
<p>This could be an explanation (we mention it in the new version), although it is not something we can prove, or at least in this study.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Recommendations for the authors):</bold></p>
<p>The work is well written, very organized, and brings important contributions both to malaria control efforts in Mozambique and to the scientific community. Based on detailed datasets from Mozambique, the authors present a novel Bayesian approach to classify malaria cases as either imported or locally acquired. Understanding the origin of cases is essential for designing more effective control measures and elimination strategies. My review focuses on the Bayesian approach as well as on a few aspects of the presentation of results.</p>
<p>The authors combine travel history, parasite genetic relatedness, and transmission intensity from different areas to compute the probability of infection occurring in the study area, given the P. falciparum genome. The Bayesian rationale is sound and well justified; however, the formulation appears to present an inconsistency that is replicated in both the main text and the Supplementary Material. According to Bayes' Rule:</p>
<p>P(I_A |G) = (P(I_A) ∙ P(G|I_A)) / (P(G)),</p>
<p>with</p>
<p>P(I_A) = K ∙ T_A ∙ PR_A,</p>
<p>P(G│I_A) = R'_A,</p>
<p>and assuming</p>
<p>P(I_A│G) + P(I_B│G) = 1,</p>
<p>the expression,</p>
<p>(T_A ∙ PR_A ∙ R'_A) / (T_A ∙ PR_A ∙ R'_A + T_B ∙ PR_B ∙ R'_B)</p>
<p>appears to refer to P(I_A│G), not to P(I_A) (as indicated in the main text and Supplementary Material).</p>
<p>P(I_A│G) + P(I_B│G) = (P(I_A) ∙ P(G|I_A) + P(I_B) ∙ P(G|I_B)) / P(G) = 1</p>
<p>⇒P(G) = P(I_A) ∙ P(G|I_A) + P(I_B) ∙ P(G|I_B)</p>
<p>⇒P(G) = K ∙ T_A ∙ PR_A ∙ R'_A + K ∙ T_B ∙ PR_B ∙ R'_B</p>
<p>⇒P(I_A│G) = (T_A ∙ PR_A ∙ R'_A) / (T_A ∙ PR_A ∙ R'_A + T_B ∙ PR_B ∙ R'_B)</p>
<p>Please clarify this.</p>
</disp-quote>
<p>As mentioned in a previous comment, we acknowledge this point from the reviewer.  In fact, the final formula corresponds to <italic>P</italic>(<italic>IA | G</italic>), instead of <italic>P</italic>(<italic>IA</italic>), so:</p>
<disp-formula id="sa4equ3">
<graphic mime-subtype="jpg" xlink:href="elife-107136-sa4-equ3.jpg" mimetype="image"/>
</disp-formula>
<p>instead of</p>
<disp-formula id="sa4equ4">
<graphic mime-subtype="jpg" xlink:href="elife-107136-sa4-equ4.jpg" mimetype="image"/>
</disp-formula>
<p>We have now corrected this error in the new version of the manuscript and in the supplementary information.</p>
<disp-quote content-type="editor-comment">
<p>Additional comments:</p>
<p>(1) Figure 3A has a scale that includes negative values, which is not reasonable for R.</p>
</disp-quote>
<p>We agree that R estimates are not compatible with negative values. The intention of this scale was to show the overall mean R in the centre, in white, so that blue colours represented values below the average and red values above the average. However, we proceeded to update the figures according to your recommendations.</p>
<disp-quote content-type="editor-comment">
<p>(2) I suggest using a common scale from 0 to 0.12 (maximum values among panels) across panels A, C, and D, as well as in Sup Fig 3, to facilitate comparison.</p>
</disp-quote>
<p>We updated the figures according to the recommendations.</p>
<disp-quote content-type="editor-comment">
<p>(3) The x-axis labels in Figure 3A and Supplementary Figure 2A are not aligned with the x-axis ticks.</p>
</disp-quote>
<p>We updated the figures so that the alignment in the x-axis is clear.</p>
<disp-quote content-type="editor-comment">
<p>(4) Supplementary Figure 5 would be better presented if the data were divided into four separate panels.</p>
</disp-quote>
<p>We have divided the figure into four separate panels.</p>
<disp-quote content-type="editor-comment">
<p>(6) Figure 5D is not referenced in the main text.</p>
</disp-quote>
<p>We missed the mention, which is now fixed in the new version.</p>
<disp-quote content-type="editor-comment">
<p>(7) The authors state: &quot;No significant differences in R were found comparing parasite samples from Magude and the rest of the districts.&quot; However, Supplementary Figure 3 shows statistically significant relatedness between parasites from Magude and Matutuine. Please clarify this.</p>
</disp-quote>
<p>Answer: we added clarity to this sentence which was indeed confusing.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #3 (Recommendations for the authors):</bold></p>
<p>(1) Introduction: More background info about malaria in Mozambique would be appreciated.</p>
</disp-quote>
<p>We included some contextualisation about malaria in Mozambique and our study districts.</p>
<disp-quote content-type="editor-comment">
<p>(2) Why were most of the samples collected from children? Is malaria most prevalent in that group? Information could be added in the introduction.</p>
</disp-quote>
<p>Children are usually considered an appropriate sentinel group for malaria surveillance for several reasons. First, most malaria cases reported from symptomatic outpatient visits are children, especially in areas with moderate to high burden. Second (and probably the cause for the first reason), their lower immunity levels, due to lower time of exposure, and their immature system, provides a cleaner scenario of the effects of malaria, since the body response is less adapted from past exposures. Finally, as a vulnerable population, they deserve a stronger focus in surveillance systems. We added a comment in the introduction referring to them as a common sentinel group for surveillance.</p>
<disp-quote content-type="editor-comment">
<p>(3) Minor: Check spaces in the text (for example, line 333 and the start of the Discussion).</p>
</disp-quote>
<p>Thank you for noticing, we fixed in in the new version</p>
<disp-quote content-type="editor-comment">
<p>(4) Minor: In my case, the micro (u) symbol can be observed in Word, but not in PDF.</p>
</disp-quote>
<p>One of the symbols produced an error, we hope that the new version is correct now.</p>
<disp-quote content-type="editor-comment">
<p>(5) Were COI calculations with MOIRE performed across provinces and regions, or taking all samples as one population?</p>
</disp-quote>
<p>Wwe took all samples as one population. However, we validated that the same results (reaching equivalent numbers and the same conclusions) were obtained when run across different populations (regions or provinces). We mention this in the manuscript now.</p>
<disp-quote content-type="editor-comment">
<p>(6) Have you tested lower values than 0.04 for PR in Maputo?</p>
</disp-quote>
<p>This would not have had any impact in the classification. Only two individuals reported a trip to Maputo city (where we assumed PR=0.04), and none of them were classified as imported. If lower values of PR were assumed, their probabilities of importation would have reduced, so that we would still obtain no imported cases.</p>
<disp-quote content-type="editor-comment">
<p>(7) Map (Supplementary Figure 1): Please, improve the resolution (like in the zoom in) and add a scale and a compass rose.</p>
</disp-quote>
<p>We improved the resolution of the map. We did not add a scale and a compass rose, but labelled the coordinates as longitude and latitude to clarify the scale and orientation of the map. We added this in the rest of the maps of the manuscript as well.</p>
<disp-quote content-type="editor-comment">
<p>(8) In this work, Pimp values were bimodal to 0 or 1, making the classification easy. I wonder in other scenarios, where Pimp values are more intermediate (0.4-0.6), is the threshold at 0.5 still useful? Is there another way, like having a confidence interval of Pimp, to ensure the final classification? A discussion on this topic may be appreciated.</p>
</disp-quote>
<p>In this case, we would recommend doing probabilistic analyses, keeping the probability of being imported as the final outcome, and quantifying the importation rates from the weighted sum of probabilities across individuals. We added this clarification in the Methods section: “ In case of obtaining a higher fraction of intermediate values (0.4-0.6), weighted sums of individual probabilities would be more appropriate to better quantify importation rates.”</p>
<disp-quote content-type="editor-comment">
<p>(9) Results: More details per panel, not as the whole figure (Figure 2B, Figure 3A, etc) in the manuscript would be appreciated.</p>
</disp-quote>
<p>We appreciate the comment and added more details</p>
<disp-quote content-type="editor-comment">
<p>(10) Figure 3: Please, add a color legend in panel B (not only in the caption, but in the panel, such as in A, C, D).</p>
</disp-quote>
<p>We added a color legend in panel B.</p>
<disp-quote content-type="editor-comment">
<p>(11) Do the authors recommend routine surveillance to detect importation in Mozambique, or are these results solid enough to propose strategies? How possible is it that importation rates vary in the future in the south? If so, how feasible is it to implement all this process (including the amplicon sequencing) routinely?</p>
</disp-quote>
<p>We added the following text in the discussion: “While these results propose programmatic strategies for the two study districts, routine surveillance to detect importation in Mozambique would allow for identifying new strategies in other districts aiming for elimination, as well as monitoring changes in importation rates in Magude and Matutuine in the future. If scaling molecular surveillance is not feasible, travel reports could be integrated in the routing surveillance to extrapolate the case classification based on the results of this study. “</p>
<disp-quote content-type="editor-comment">
<p>(12) Which other proxies of transmission intensity could have been used?</p>
</disp-quote>
<p>Better proxies of transmission intensity could be malaria incidence at the monthly level from national surveillance systems, or estimates of force of infection, for example from the use of molecular longitudinal data if available. We added this text in the discussion.</p>
<disp-quote content-type="editor-comment">
<p>(13) Can this strategy be applied to P. vivax-endemic areas outside Africa?</p>
</disp-quote>
<p>This new method can also be applied to <italic>P. vivax</italic>-endemic areas outside Africa. Symptomatic <italic>P. vivax</italic> cases are not necessarily reflecting recent infections, so that travel reports might need to cover longer time periods, which does not require any essential adaptation to the method. We added this text to the discussion.</p>
</body>
</sub-article>
</article>